International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
www.ijsr.net | Most Trusted Research Journal Since Year 2012

ISSN: 2319-7064



Research Paper | Medicine Science | Egypt | Volume 6 Issue 5, May 2017

Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients

Nashwa El-Khazragy, Maiada A. Hussien, Mohamed A. El-Mordy, Amany M. Maher

Hepatitis C virus becomes a one of the top curable chronic diseases worldwide, this was referred to the remarkable efficacy of antiviral therapy, however, many cases showed resistance to interferon/Ribavirin combination therapy. Genetic polymorphism is the major cause of relapse after therapy. To determine whether Hepatitis C virus (HCV) core substitution and IL-28 (rs8099917) play a role in the response to INF/RBV antiviral therapy, 115 HCV chronically infected patients initiated treatment with Peglated INF plus ribavirin (INF/RBV) for 48 weeks were tested for baseline substitution at codon 70 of the viral core protein and for genetic polymorphism in IL-28 rs8099917 (TaqMan Probe assay, Applied Biosystems). In this study, we observed that, TT genotype in IL-28 polymorphism was the favourable genotype as 75 % of this genotype achieved therapeutic success, defined as sustained viral response at 12 weeks of therapy. 23.5 % of studied patients presented a mutant HCV core substitution at core position 70, those were resistant to therapy and failed to achieve a viral response. A multivariate analysis revealed three independent predictors of therapeutic success age40years (P<0.001), IL-28 rs8099917 genotype (P=0.04) and absence of HCV core substitution at position 70 (P<0.001). This study concluded that IL-28 rs8099917 and HCV core mutations can be considered as predictors for therapeutic response to INF/RBV therapy, so those who are affordable should treated with direct acting antiviral drugs (DAAs) rather than INF based therapy to prevent evolution towards end-stage liver disease.

Keywords: Hepatitis C virus, IL-28 rs8099917, INF/RBV antiviral therapy, HCV core substitution

Edition: Volume 6 Issue 5, May 2017

Pages: 1187 - 1192


How to Cite this Article?

Nashwa El-Khazragy, Maiada A. Hussien, Mohamed A. El-Mordy, Amany M. Maher, "Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20173368, Volume 6 Issue 5, May 2017, 1187 - 1192

23 PDF Views | 26 PDF Downloads

Download Article PDF



Similar Articles with Keyword 'Hepatitis C virus'

Research Paper, Medicine Science, Egypt, Volume 4 Issue 11, November 2015

Pages: 1713 - 1720

Prevalence of Hepatitis C Infection among Diabetics Type 2 at Sharkia Governorate, Egypt

Adel AM Ghorab, Walid M Afifi, Yasser Elnaggar, Amal A. Zidan MD

Share this article

Research Paper, Medicine Science, Sudan, Volume 5 Issue 10, October 2016

Pages: 1258 - 1261

Hepatitis C Viral Infection among Health Care Workers at Dialysis Centers in Khartoum State, Sudan

Eltagi Abdalla Mohammed Abdalla, Kamil Merrghani Ali Shappan

Share this article

Research Paper, Medicine Science, Egypt, Volume 6 Issue 5, May 2017

Pages: 1187 - 1192

Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients

Nashwa El-Khazragy, Maiada A. Hussien, Mohamed A. El-Mordy, Amany M. Maher

Share this article

Research Paper, Medicine Science, Albania, Volume 6 Issue 4, April 2017

Pages: 2217 - 2219

Prevalence of HCV Virus among Thalassemia Patients in Albania

Pranvera Doci, Tatjana Nurka, Edi Dragusha, Renata Shkjezi

Share this article

Research Paper, Medicine Science, Albania, Volume 5 Issue 12, December 2016

Pages: 484 - 487

Distribution of HCV Genotype among the Patients Treated for Chronic Hepatitis C in Albania

Stela Taci, Sonela Xinxo, Jovan Basho

Share this article
Top